NCT03913819 - Treatment Outcomes Under a Standardized Treatment Protocol in Patients Suffered Substance Abuse Related Voiding Dysfunction | Biotech Hunter

Enrollment

1,000

Participants

Timeline

Start Date

December 10, 2011

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Voiding DysfunctionSubstance Abuse

Interventions

DRUG

First line treatment: oral NSAID and anticholinergic agents

oral NSAID and anticholinergic agents

DRUG

Second line treatment: additional treatment for pain control

Gabapentin, tramadol, Lyrica

DRUG

Third line treatment: A course of intravesical hyaluronate will be given.

A course of intravesical hyaluronate will be given.

PROCEDURE

Fourth line treatment: surgical intervention

Consideration of hydrodistention and augmentation cystoplasty

Trial Locations (1)

RECRUITING

Prince of Wales Hospital, Shatin

All Listed Sponsors

lead

Chinese University of Hong Kong

OTHER